(Note: This episode was recorded on November 7, 2024)

The results of the 2024 elections are in: Donald Trump will be the 47th President of the United States, and we are all but certain to have a Republican trifecta at the federal level. Admittedly, there’s a lot we don’t know about what healthcare will look like under a second Trump administration—a lot will depend on who is appointed to key leadership positions overseeing federal health agencies and Congressional committees. But while we wait for those appointments, what can we anticipate based on President-elect Trump’s first term, campaign, and the Republican platform?

This week, hosts Rachel (Rae) Woods and Abby Burns invite Advisory Board experts Natalie Trebes and Ben Palmer to break down the implications of a second Trump term on the healthcare industry. They unpack how power dynamics have shifted since the first administration, and what we’re likely to see on issues like the ACA, enhanced subsidies, Medicaid, drug pricing, abortion, and more.

Links:

Join 165,000+ healthcare leaders and get the industry’s most important news in your inbox—every day.

A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.

230: Elections results are in: What healthcare leaders need to know

Radio Advisory